Cargando…

Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria

Detalles Bibliográficos
Autor principal:	Heo, Young-A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284976/ https://www.ncbi.nlm.nih.gov/pubmed/37261622 http://dx.doi.org/10.1007/s40265-023-01898-1

Ejemplares similares

Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
por: Heo, Young-A
Publicado: (2022)

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Bresnahan, Rebecca, et al.
Publicado: (2023)

Normalisation of haemoglobin and control of breakthrough haemolysis with increased frequency pegcetacoplan dosing in treated paroxysmal nocturnal haemoglobinuria
por: Davis, Amanda K., et al.
Publicado: (2023)

Ravulizumab for paroxysmal nocturnal haemoglobinuria
Publicado: (2022)

Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond S.M.
Publicado: (2022)

Paroxysmal nocturnal haemoglobinuria and diabetes mellitus.
por: Andrews, W. J., et al.
Publicado: (1990)

Coombs-positive Paroxysmal Nocturnal Haemoglobinuria
por: Kalam, Sabrina, et al.
Publicado: (2020)

PB2043: CLINICAL EFFECTIVENESS, TREATMENT USE, SATISFACTION AND IMPACT ON QUALITY-OF-LIFE OF PEGCETACOPLAN TREATMENT FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH).
por: Wilson, Koo, et al.
Publicado: (2023)

Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety
por: Shah, Sangam, et al.
Publicado: (2022)

Paroxysmal Nocturnal Haemoglobinuria: Clinical-Pathological Conference
por: Hewer, T. F.
Publicado: (1963)

Pegcetacoplan ‐ a novel C3 inhibitor for paroxysmal nocturnal hemoglobinuria
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2022)

Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
por: Cançado, Rodolfo D., et al.
Publicado: (2021)

Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
por: Wong, Raymond, et al.
Publicado: (2023)

C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
por: de Castro, Carlos, et al.
Publicado: (2020)

PB2054: EXPOSURE-RESPONSE ANALYSES OF PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Ping, Haili, et al.
Publicado: (2023)

Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond Siu Ming, et al.
Publicado: (2023)

Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
por: Bosi, Alessandro, et al.
Publicado: (2022)

Tozinameran: Flare up of paroxysmal nocturnal haemoglobinuria: case report
Publicado: (2022)

Paroxysmal Hæmoglobinuria
Publicado: (1910)

Paroxysmal Hæmoglobinuria
Publicado: (1903)

Paroxysmal Hæmoglobinuria
por: Campbell, F. R.
Publicado: (1887)

PB2053: POPULATION PHARMACOKINETICS OF PEGCETACOPLAN IN HEALTHY SUBJECTS AND PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Ping, Haili, et al.
Publicado: (2023)

The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA
por: Fishman, Jesse, et al.
Publicado: (2023)

Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond S. M., et al.
Publicado: (2022)

Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients
por: Adhikari, Sugat, et al.
Publicado: (2023)

Primary myelofibrosis with concurrent paroxysmal nocturnal haemoglobinuria presenting with erectile dysfunction
por: Alsalman, Zaenb, et al.
Publicado: (2022)

How we(’ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future
por: Risitano, Antonio Maria, et al.
Publicado: (2021)

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review
por: Devalet, Bérangère, et al.
Publicado: (2014)

Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment
por: Moriyama, Mitsuru, et al.
Publicado: (2021)

P794: EVALUATION OF PEGCETACOPLAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH APLASTIC ANEMIA IN THE PRINCE STUDY
por: Bogdanovic, Andrija, et al.
Publicado: (2023)

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
por: Dragoni, Francesco, et al.
Publicado: (2018)

Paroxysmal nocturnal haemoglobinuria (PNH) manifesting on CT as a pathologic segment of small bowel
por: Zekria, David, et al.
Publicado: (2017)

Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
por: Hillmen, Peter, et al.
Publicado: (2013)

COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria
por: Pike, Alexandra, et al.
Publicado: (2022)

A Case of Paroxysmal Hæmoglobinuria
por: Gemmell, William
Publicado: (1896)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report
por: Sharma, Vivek, et al.
Publicado: (2023)

Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts
por: Ratajczak, Mariusz Z, et al.
Publicado: (2015)

Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study
por: Liu, Limin, et al.
Publicado: (2022)

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis
por: Socié, Gérard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_durdsm3d3el9cnn45glk5l80h4